Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gene therapy progress and prospects: Parkinson's disease.

× No keyword cloud information.

16 in total

Review 1. Human gene therapy and imaging in neurological diseases.

Authors: Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal: Eur J Nucl Med Mol Imaging Date: 2005-12 Impact factor: 9.236

Review 2. Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

Authors: Ronald J Mandel; Corinna Burger; Richard O Snyder
Journal: Exp Neurol Date: 2007-08-24 Impact factor: 5.330

3. Long-term transgene expression in mouse neural progenitor cells modified with phiC31 integrase.

Authors: Annahita Keravala; Brandi K Ormerod; Theo D Palmer; Michele P Calos
Journal: J Neurosci Methods Date: 2008-06-17 Impact factor: 2.390

4. Combinatorial evaluation of cations, pH-sensitive and hydrophobic moieties for polymeric vector design.

Authors: Sharon Y Wong; Nimil Sood; David Putnam
Journal: Mol Ther Date: 2009-01-13 Impact factor: 11.454

5. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.

Authors: Alevtina D Zharikov; Jason R Cannon; Victor Tapias; Qing Bai; Max P Horowitz; Vipul Shah; Amina El Ayadi; Teresa G Hastings; J Timothy Greenamyre; Edward A Burton
Journal: J Clin Invest Date: 2015-06-15 Impact factor: 14.808

6. Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles.

Authors: Jung Soo Suk; Junghae Suh; Kokleong Choy; Samuel K Lai; Jie Fu; Justin Hanes
Journal: Biomaterials Date: 2006-10 Impact factor: 12.479

Review 7. A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.

Authors: Shams Tabrez; Nasimudeen R Jabir; Shazi Shakil; Nigel H Greig; Qamre Alam; Adel M Abuzenadah; Ghazi A Damanhouri; Mohammad A Kamal
Journal: CNS Neurol Disord Drug Targets Date: 2012-06-01 Impact factor: 4.388

8. Neuronal expression of the transcription factor Gli1 using the Talpha1 alpha-tubulin promoter is neuroprotective in an experimental model of Parkinson's disease.

Authors: D Suwelack; A Hurtado-Lorenzo; E Millan; V Gonzalez-Nicolini; K Wawrowsky; P R Lowenstein; M G Castro
Journal: Gene Ther Date: 2004-12 Impact factor: 5.250

9. Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration.

Authors: A Hurtado-Lorenzo; E Millan; V Gonzalez-Nicolini; D Suwelack; M G Castro; P R Lowenstein
Journal: Mol Ther Date: 2004-09 Impact factor: 11.454

10. Antioxidant and astroprotective effects of a Pulicaria incisa infusion.

Authors: Anat Elmann; Alona Telerman; Sharon Mordechay; Hilla Erlank; Rivka Ofir
Journal: Oxid Med Cell Longev Date: 2012-12-23 Impact factor: 6.543